Table 1.
Demographics of the study population
| Characteristic | Population overall n (%) |
Individuals vaccinated n (%) n = 29 785 |
Individuals not vaccinated n (%) n = 736 545 |
|---|---|---|---|
| Age (years)a | |||
| 65–69 | 209 992 (27.4) | 8805 (29.6) | 201 187 (27.3) |
| 70–74 | 160 022 (20.9) | 7994 (26.8) | 152 028 (20.6) |
| 75–79 | 141 884 (18.5) | 6127 (20.6) | 135 757 (18.4) |
| ≥80 | 254 432 (33.2) | 6859 (23.0) | 247 573 (33.6) |
| Gender | |||
| Male | 247 940 (32.4) | 9111 (30.6) | 238 829 (32.4) |
| Female | 518 390 (67.7) | 20 674 (69.4) | 497 716 (67.6) |
| Raceb | |||
| White | 646 803 (84.4) | 27 889 (93.6) | 618 914 (84.0) |
| Black | 66 506 (8.7) | 387 (1.3) | 66 119 (9.0) |
| Other | 52 046 (6.8) | 1509 (5.1) | 51 512 (7.0) |
| Low income | |||
| No | 570 182 (74.4) | 27 405 (92.0) | 542 777 (73.7) |
| Yes | 196 148 (25.6) | 2380 (8.0) | 193 768 (26.3) |
| CKD | |||
| No | 582 568 (76.0) | 25 261 (84.8) | 557 307 (75.7) |
| Yes | 183 762 (24.0) | 4524 (15.2) | 179 238 (24.3) |
| Stage unavailable | 107 101 (58.3) | 2661 (8.9) | 104 440 (14.2) |
| CKD Stage 1 | 4702 (0.6) | 136 (0.5) | 4566 (0.6) |
| CKD Stage 2 | 8348 (1.1) | 274 (0.9) | 8704 (1.1) |
| CKD Stage 3 | 37 142 (4.9) | 1123 (3.8) | 36 019 (4.9) |
| CKD Stage 4 | 10 039 (1.3) | 166 (0.6) | 9.873 (1.3) |
| CKD Stage 5 | 16 430 (2.1) | 164 (0.1) | 16 266 (2.2) |
| CKD Stage 5—on renal replacement therapy | |||
| On dialysis | 11 742 (1.5) | 97 (0.3) | 11 645 (1.6) |
| Renal transplantation | 773 (0.1) | 15 (0.1) | 758 (0.1) |
| Diabetes mellitus | |||
| No | 466 315 (60.9) | 21 029 (70.6) | 445 286 (60.5) |
| Yes | 300 015 (39.2) | 8756 (29.4) | 291 259 (39.5) |
| CKD and diabetes mellitus | |||
| No | 660 304 (86.2) | 27 569 (92.6) | 632 735 (85.9) |
| Yes | 106 026 (13.8) | 2216 (7.4) | 103 810 (14.1) |
aFor determination of numbers, age at vaccination used if vaccinated; otherwise baseline age.
bMissing race information for 975 people (0.1%).